Indication
Exfoliative dermatitis
Exfoliative dermatitis, clinically synonymous with erythroderma, is a severe, potentially life-threatening inflammatory disorder of the integumentary system characterized by widespread erythema and extensive scaling or peeling involving at least 90% of the body surface area. Read more about Exfoliative dermatitis
334 drugs 161 manufacturers
Drugs that treat it
Common Exfoliative dermatitis therapies.
SOLU-MEDROL (methylprednisolone sodium succinate/PF)
SOLU-MEDROL (methylprednisolone sodium succinate/PF)
SOLU-CORTEF (hydrocortisone sodium succinate/PF)
PREDNISOLONE
BETAMETHASONE SOD PHOS-ACETATE (betamethasone acetate/betamethasone sodium phosphate)
SOLU-CORTEF (hydrocortisone sodium succinate)
DEPO-MEDROL (methylprednisolone acetate)
MEDROL (methylprednisolone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonExfoliative dermatitis, clinically synonymous with erythroderma, is a severe, potentially life-threatening inflammatory disorder of the integumentary system characterized by widespread erythema and extensive scaling or peeling involving at least 90% of the body surface area.
It typically arises as a cutaneous reaction pattern triggered by preexisting dermatoses, adverse drug reactions, underlying malignancies, or idiopathic factors.
Pathophysiologically, dramatic cutaneous vasodilation and accelerated epidermal turnover severely disrupt the epithelial barrier, frequently causing complications such as hypothermia, high-output cardiac failure, fluid and electrolyte imbalances, hypoalbuminemia, and heightened vulnerability to secondary cutaneous infections.
- nih.gov
Exfoliative dermatitis, clinically synonymous with erythroderma, is a severe, potentially life-threatening inflammatory disorder of the integumentary system characterized by widespread erythema and extensive scaling or peeling involving at least 90% of the body surface area It typically arises as a cutaneous reaction pattern triggered by preexisting dermatoses, adverse drug reactions, underlying malignancies, or idiopathic factors
- pcds.org.uk
Exfoliative dermatitis, clinically synonymous with erythroderma, is a severe, potentially life-threatening inflammatory disorder of the integumentary system characterized by widespread erythema and extensive scaling or peeling involving at least 90% of the body surface area Pathophysiologically, dramatic cutaneous vasodilation and accelerated epidermal turnover severely disrupt the epithelial barrier, frequently causing complications such as hypothermia, high-output cardiac failure, fluid and el...
- nih.gov
It typically arises as a cutaneous reaction pattern triggered by preexisting dermatoses, adverse drug reactions, underlying malignancies, or idiopathic factors Pathophysiologically, dramatic cutaneous vasodilation and accelerated epidermal turnover severely disrupt the epithelial barrier, frequently causing complications such as hypothermia, high-output cardiac failure, fluid and electrolyte imbalances, hypoalbuminemia, and heightened vulnerability to secondary cutaneous infections
- clfoundation.org
Pathophysiologically, dramatic cutaneous vasodilation and accelerated epidermal turnover severely disrupt the epithelial barrier, frequently causing complications such as hypothermia, high-output cardiac failure, fluid and electrolyte imbalances, hypoalbuminemia, and heightened vulnerability to secondary cutaneous infections
Personalize your experience
Follow Exfoliative dermatitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.